|
Agios Pharmaceuticals
|
30.28 |
|
-0.56 |
-1.82% |
4.92% |
2025-03-28 |
|
Alnylam Pharmaceuticals
|
268.46 |
|
-2.56 |
-0.94% |
75.09% |
2025-03-28 |
|
Amgen
|
307.20 |
|
1.31 |
0.43% |
8.54% |
2025-03-28 |
|
Arrowhead Research
|
13.82 |
|
0.02 |
0.14% |
-51.06% |
2025-03-28 |
|
Tectonic Therapeutic
|
18.65 |
|
-0.26 |
-1.37% |
21.37% |
2025-03-28 |
|
Biogen
|
138.42 |
|
-2.11 |
-1.50% |
-35.57% |
2025-03-28 |
|
BioMarin Pharmaceutical
|
71.44 |
|
-1.39 |
-1.91% |
-17.98% |
2025-03-28 |
|
Gilead Sciences
|
111.84 |
|
0.60 |
0.54% |
53.46% |
2025-03-28 |
|
Incyte
|
60.60 |
|
-0.08 |
-0.13% |
6.99% |
2025-03-28 |
|
Ionis Pharmaceuticals
|
31.15 |
|
-0.57 |
-1.80% |
-29.11% |
2025-03-28 |
|
Moderna
|
31.13 |
|
-1.02 |
-3.16% |
-70.53% |
2025-03-28 |
|
Novartis
|
98.62 |
|
0.33 |
0.34% |
15.08% |
2025-03-28 |
|
Pfizer
|
25.19 |
|
0.13 |
0.52% |
-9.13% |
2025-03-28 |
|
PTC Therapeutics
|
54.24 |
|
-0.75 |
-1.36% |
89.72% |
2025-03-28 |
|
Ultragenyx Pharmaceutical
|
37.82 |
|
-1.07 |
-2.75% |
-19.48% |
2025-03-28 |
|
Regeneron Pharmaceuticals
|
637.72 |
|
1.45 |
0.23% |
-34.21% |
2025-03-28 |
|
Sarepta Therapeutics
|
70.41 |
|
-1.40 |
-1.95% |
-45.16% |
2025-03-28 |
|
Vertex Pharmaceuticals
|
492.21 |
|
-10.53 |
-2.09% |
17.06% |
2025-03-28 |